Mutations in MYOZ1 as well as MYOZ2 encoding the calsarcins are not associated with idiopathic and familial dilated cardiomyopathy

Molecular Genetics and Metabolism

Volumn 91, Issue 2, 2007, Pages 207-208

  Posch, Maximilian G ^a   Perrot, Andreas ^a   Dietz, Rainer ^a   Özcelik, Cemil ^a   Pankuweit, Sabine ^b   Ruppert, Volker ^b   Richter, Anette ^b   Maisch, Bernhard ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN CALSARCIN 1; PROTEIN CALSARCIN 2; UNCLASSIFIED DRUG;

CARDIOMYOPATHY; CLINICAL EXAMINATION; CONGESTIVE CARDIOMYOPATHY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA POLYMORPHISM; FAMILIAL DISEASE; GENE; GENE MUTATION; GENE SEQUENCE; HUMAN; LETTER; MYOZ1 GENE; MYOZ2 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

CARDIOMYOPATHY, DILATED; CARRIER PROTEINS; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; POLYMORPHISM, GENETIC;

EID: 34249077977     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.02.014     Document Type: Letter

References (8)

1. Arola A.M., Sanchez X., Murphy R.T., Hasle E., Li H., Elliot P.M., McKenna W.J., Towbin J.A., and Bowles N.E. Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathy. Mol. Genet. Metab. (2007) 10.1016/j.ymgme.2006.12.008
2. Mestroni L., Maisch B., McKenna W.J., Schwartz K., Charron P., Rocco C., Tesson F., Richter A., Wilke A., and Komajda M. Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur. Heart J. 20 (1999) 93-102
3. Perrot A., Sigusch H.H., Nagele H., Genschel J., Lehmkuhl H.B., Hetzer R., Geier C., Leon Perez V., Reinhard D., Dietz R., Osterziel K.J., and Schmidt H.H. Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: demand for strategies in the management of presymptomatic lamin A/C mutant carriers. Eur. J. Heart Fail. 8 (2006) 484-493
4. Geier C., Perrot A., Ozcelik C., Binner P., Counsell D., Hoffmann K., Pilz B., Martiniak Y., Gehmlich K., van der Ven P.F., Furst D.O., Vornwald A., von Hodenberg E., Nurnberg P., Scheffold T., Dietz R., and Osterziel K.J. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 107 (2003) 1390-1395
5. Faulkner G., Pallavicini A., Comelli A., Salamon M., Bortoletto G., Ievolella C., Trevisan S., Kojic S., Dalla Vecchia F., Laveder P., Valle G., and Lanfranchi G. FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle. J. Biol. Chem. 275 (2000) 41234-41242
6. Frey N., Richardson J.A., and Olson E.N. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl. Acad. Sci. USA 97 (2000) 14632-14637
7. Frey N., Barrientos T., Shelton J.M., Frank D., Rutten H., Gehring D., Kuhn C., Lutz M., Rothermel B., Bassel-Duby R., Richardson J.A., Katus H.A., Hill J.A., and Olson E.N. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. Med. 12 (2004) 1336-1343
8. Zeller R., Ivandic B.T., Ehlermann P., Mucke O., Zugck C., Remppis A., Giannitsis E., Katus H.A., and Weichenhan D. Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE. J. Mol. Med. 84 (2006) 682-691